ChineseChina UKUK DeutschlandDeutschland FranceFrance РоссияРоссия 한국한국 ไทยไทย Việt NamViệt Nam العربيةالعربية ҚазақстанҚазақстан EspañaEspaña MyanmarMyanmar DaiDai

Linking China’s Premium Healthcare · Serving Global Health Needs

Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties

One-Stop Medical Care in China

  • International flights · Airport pickup · Nearby hotels
  • Multilingual interpreters · Full medical escort
  • Expert matching · Hospital fast-track
  • Full-cycle treatment · Post-op follow-up
Sign in

Ms. Zara is suffering from cancer.

Patient basic information Patient: Ms. Zara (Zara Perez) Nationality: Portugal Disease diagnosis: Esophageal cancer Diagnostic hospital: H0C0 treatment: Inner lens treatment + medication Dates of hospitalization: 55 days Treatment cost: about 1225492 yuan Treatment effect: Stability of the disease Description of the disease Ms. Zara is from Portugal and was diagnosed with esophageal cancer locally.

Upon arrival, the International Medical Services Team arranged for the first time multidisciplinary MDT clinics for patients, developed individualized clinical pathways based on patient inspection reports and physical conditions, and provided translation, guidance and on-site services throughout the treatment process. After 55 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and various test indicators returned to normal areas, successfully reaching the hospital standard. Treatment results The patient's final condition stabilized.

When he left the hospital, the medical team developed a detailed return follow-up and rehabilitation plan for him and continued to track recovery through the remote follow-up system. 'Ladies and gentlemen, Ms. Zara, experts have criticized this case as a typical case of cross-border suspected seriousness clinical cases.

The multi-disciplinary collaborative mechanism for the development of an intracellular treatment + drug program for esophageal cancer, which reflects the comprehensive strength of Chinese hospitals in the field of suspected disease clinics, and a summary of how international medical services are regulated.

葡萄牙,食管癌,郑州大学第一附属医院,国际医疗,来华就医,中国医疗